Navigation Links
Drug Given 24 Hours After Stroke Helps Repair Brain Tissue
Date:9/3/2008

Bryostatin may also work in patients with Alzheimer's and traumatic injury, study says

WEDNESDAY, Sept. 3 (HealthDay News) -- A little-used cancer drug called bryostatin can repair brain tissue if it's administered within 24 hours after a stroke, according to U.S. researchers.

Current stroke treatments must be administered within three hours and aren't able to repair damaged brain tissue, the scientists said.

"Today's stroke patient has precious minutes to receive care without suffering irreversible damage or death. One of the greatest challenges in modern medical practice is finding an effective treatment that extends that treatment time and repairs damage. Bryostatin could be an answer," Dr. Daniel Alkon, scientific director at the Blanchette Rockefeller Neurosciences Institute, said in an institute news release.

In an article in the Sept. 3 issue of the Proceedings of the National Academy of Sciences, Alkon and colleague Professor Miao-Kun Sun describe how bryostatin -- which is being investigated as a treatment for Alzheimer's disease -- repairs the brain and improves memory.

More than 780,000 strokes occur each year in the United States. Stroke is the third leading cause of death in the United States and the leading cause of long-term disability in the developing world. Almost 75 percent of all strokes occur in people older than 65, and the risk of suffering a stroke more than doubles each decade after age 55, according to background information in the news release.

"We're facing an aging Baby Boomer population, an influx of 55-plus Americans, and treatment that is less time-restrictive and able to repair the brain if a stroke destroys tissue is urgently needed," Alkon said.

In animal tests, bryostatin rescued dying neurons, stimulated the growth of new neuron connections, and restored memory. The drug is effective when administered up to 24 hours after a stroke, according to the researchers.

The drug may also prove effective in preventing and/or reversing brain degeneration in patients with Alzheimer's disease and traumatic brain injury, Alkon said.

The researchers are in discussion with the U.S. Food and Drug Administration to begin clinical trials of the drug.

More information

The U.S. Food and Drug Administration has more about stroke prevention and treatment.



-- Robert Preidt



SOURCE: Blanchette Rockefeller Neurosciences Institute, news release, Sept. 3, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. More sick leave given to men by male GPs compared with female counterparts
2. 10 Million Children Must Be Given a Chance
3. Promising new TB drug given special status by US and European regulators
4. Over 300 Children Are Given New Smiles
5. Bariatric Surgery Center of Excellence Designation Given to Montefiore by the American College of Surgeons
6. Pelosi: By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions
7. PartsSource Given 2008 Leading Edge Award for Second Straight Year
8. Less Intensive Treatment Given Diabetic Women With Heart Disease
9. PartsSource Given 2008 World Class Customer Service Award for Second Straight Year
10. Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008
11. Limiting Residents Hours Has Little Impact on Patient Mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, a locally ... the greater Chicago metropolitan area, is embarking on a charity drive in conjunction ... , Founded in 1897, Hephzibah Children’s Association is one of the oldest social ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is ... Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases their ... title in 2015, this marks the 3rd time that Dr. Canales has ...
(Date:6/22/2017)... ... June 22, 2017 , ... The VA Maryland ... Recycling Network has awarded the Baltimore VA Medical Center, a division of the ... for its efforts to promote waste reduction and promote recycling. Also, Practice ...
(Date:6/20/2017)... ... 2017 , ... Connance, a leading provider of healthcare predictive ... analytics drive reimbursement optimization, with a focus on denial management and claims statusing, ... traditional approach to denied and underpaid claims leaves money on the table and ...
(Date:6/20/2017)... ... June 20, 2017 , ... Fresenius Vascular Care, a national ... techniques to treat and manage a wide range of vascular conditions, has today announced ... more than 65 centers represented by more than 40 local brands, a phased rollout ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 6, 2017  Diplomat Specialty Infusion Group, a brand ... environment to its Iowa location. ... now features an ISO 7 cleanroom—the standard needed to ... with a low level of pollutants. ... nutrition consumers and better serve our Iowa ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/26/2017)... International plc (NASDAQ: ENDP ) announced today that ... Company in a fireside chat at Goldman Sachs, 38 th ... at 10:40 a.m. PT / 1:40 p.m. ET. The conference ... Palos Verdes, CA. A live webcast ... the Company,s website at http://www.endo.com/investors/overview . Participants should allow ...
Breaking Medicine Technology: